- Q1 2023 Minerva Neurosciences Inc Earnings Call TranscriptMay 15, 2023$6.44 (-11.42%)Earnings
- Q4 2022 Minerva Neurosciences Inc Earnings Call TranscriptMar 08, 2023$1.87 (-7.65%)Earnings
- Q3 2022 Minerva Neurosciences Inc Earnings Call TranscriptNov 09, 2022$3.26 (+8.85%)Earnings
- Minerva Neurosciences Inc Roluperidone Update Call TranscriptApr 13, 2022
- Q3 2021 Minerva Neurosciences Inc Earnings Call TranscriptNov 08, 2021$11.28 (+4.44%)Earnings
- Q2 2021 Minerva Neurosciences Inc Earnings Call TranscriptAug 02, 2021$14.72Earnings
- Minerva Neurosciences Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 16, 2021
- Minerva Neurosciences Inc Annual Shareholders Meeting TranscriptJun 11, 2021
- Q1 2021 Minerva Neurosciences Inc Earnings Call TranscriptMay 12, 2021$20.64 (+15.70%)Earnings
- Q4 2020 Minerva Neurosciences Inc Earnings Call TranscriptMar 08, 2021$25.52 (+11.54%)Earnings
- Q3 2020 Minerva Neurosciences Inc Earnings Call TranscriptNov 02, 2020$24.8 (-3.43%)Earnings
- Minerva Neurosciences Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Q2 2020 Minerva Neurosciences Inc Earnings Call TranscriptAug 03, 2020$29.52 (+5.88%)Earnings
- Minerva Neurosciences Inc Annual Shareholders Meeting TranscriptJun 19, 2020
- Minerva Neurosciences, Inc. - Special Call TranscriptJun 05, 2020
- Q1 2020 Minerva Neurosciences Inc Earnings Call TranscriptMay 04, 2020$78 (+3.83%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 31, 2020
- Q4 2019 Minerva Neurosciences Inc Earnings Call TranscriptMar 09, 2020$57.6 (-14.59%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 06, 2020
- Minerva Neurosciences, Inc. - Special Call TranscriptDec 18, 2019
- Q3 2019 Minerva Neurosciences Inc Earnings Call TranscriptNov 04, 2019$37.2 (+0.65%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptOct 01, 2019
- Q2 2019 Minerva Neurosciences Inc Earnings Call TranscriptAug 05, 2019$55.76 (+8.06%)Earnings
- Minerva Neurosciences Inc To Discuss The Results Of Its Successful Phase 2b Clinical Trial Of Seltorexant MIN-202 In Insomnia TranscriptJun 24, 2019
- Q1 2019 Minerva Neurosciences Inc Earnings Call TranscriptMay 06, 2019$57.52 (-5.15%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 21, 2019
- Q4 2018 Minerva Neurosciences Inc Earnings Call TranscriptMar 12, 2019$64.88 (-0.37%)Earnings
Q4 2019 Minerva Neurosciences Inc Earnings Call Transcript
Welcome to the Minerva Neurosciences Year End 2019 Conference Call. (Operator Instructions)
This call is being webcast live on the Investors section of Minerva's website at ir.minervaneurosciences.com. As a reminder, today's call is being recorded.
I would now like to turn the call over to William Boni, Vice President of Investor Relations and Corporate Communications at Minerva. Please proceed.
Good morning. A press release with the company's year-end 2019 financial results and business highlights became available at 7:30 a.m. Eastern Time today and can be found on the Investors section of our website. Our annual report on Form 10-K was also filed electronically with the Securities and Exchange Commission this morning and can be found on the SEC's website at www.sec.gov.
Joining me on the call today from Minerva are Dr. Rémy Luthringer, Executive Chairman and Chief Executive Officer; Mr
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)